Fierce Healthcare April 24, 2024
Paige Minemyer

UPDATED at 1 p.m. ET on April 24

Humana pulled back its growth projections for 2025 amid concerns about Medicare Advantage rates and demographic changes.

The company’s stock dropped out of the gate and was down by 4.5% as of 1:15 p.m. ET. Humana had originally estimated between $6 and $10 in earnings per share for 2025. Humana did confirm its conservative guidance for the year, and expects about $16 in earnings per share for 2024.

Earlier this month, the Centers for Medicare & Medicaid Services finalized a 0.16% decrease in the benchmark rate in Medicare Advantage despite significant pushback from the insurance industry. Chief Operating Officer Jim Rechtin warned on Humana’s earnings call Thursday that the changes would likely...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Insurance, Medicare Advantage, Payer
Will a CEO’s Murder Nudge American Healthcare Toward the Unthinkable?
Three ways payers and providers can improve risk adjustment | Viewpoint
Florida Blue latest to sue over Medicare Advantage star ratings
Priority Health Acquires Physicians Health Plan of Northern Indiana
10 largest Medicaid managed care plans

Share This Article